Multiobjective optimization identifies cancer-selective combination therapies
Otto I. Pulkkinen, Prson Gautam, Ville Mustonen, Tero A. Aittokallio
This paper develops a multiobjective optimization method to identify cancer-selective drug combinations, validated in BRAF-V600E melanoma, showing improved selectivity through combinatorial targeting.